Sirius Investors

UBIO Stock: ProShares UltraPro Nasdaq Biotechnology Stock Price, Analysis & Insights

Get live ubio stock price $17.77, comprehensive ProShares UltraPro Nasdaq Biotechnology stock analysis, charts, news, and expert forecast. Real-time ubio stock data and investment insights.

17.77
0.00%Today
UBIOProShares UltraPro Nasdaq Biotechnology • NASDAQ Global Market • Financial Services
Market Cap
15.09M
Volume
34.71K
52W High
34.80
52W Low
13.13

Company Overview

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index® (the index). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Company Information

CEO
Sector
Financial Services
Industry
Asset Management - Leveraged
Employees
N/A

Contact Information

Website
Address
Country

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Financial Services leader with 15.09M market capitalization
  • Trading Volume: 34.71K shares traded today
  • Price Range: 52-week range of $13.13 - $34.80
  • Exchange: Listed on NASDAQ Global Market

Financial Metrics

P/E Ratio:N/A
EPS:$0.00
Beta:3.15
Avg Volume:0

Market Analysis for ProShares UltraPro Nasdaq Biotechnology

ProShares UltraPro Nasdaq Biotechnology (UBIO) operates in the Asset Management - Leveraged industry within the Financial Services sector. With a current market capitalization of 15.09M, the company represents a significant player in its market. The stock is currently trading at $17.77 with a positivedaily change of 0.00%.

The company's substantial employee base and presence on the NASDAQ Global Marketexchange position it as a Financial Services sector leader. Investors should consider the stock's P/E ratio of N/A, beta of 3.15, and 52-week price range from $13.13 to $34.80when evaluating investment opportunities.

Why Invest in ProShares UltraPro Nasdaq Biotechnology?

Strengths
  • • Established market presence in Financial Services
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Global Market)
  • • Experienced leadership under
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Financial Services Stocks

About Financial Services Sector

The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.